"In vitro" inhibition of platelet aggregation by uremic middle molecules. 1980

P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi

"Uremic middle molecules" are isolated from the urine of normal subjects and the blood in chronic renal insufficiency treated by hemodialysis. Their action is tested in vitro on platelets aggregation induced by ADP. Some fractions of these middle molecules (fractions 7b, 7c and 7 "fg") are without any effect. The 7 "de" fractions give an inhibition of platelets aggregation. The percentage variations of first phase inhibition as a function of the middle molecules concentrations is studied.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
January 1985, Nephron,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
September 1987, European journal of haematology,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
September 1983, Clinical nephrology,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
March 1981, The International journal of artificial organs,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
April 1976, Clinical nephrology,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
October 1980, Thrombosis and haemostasis,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
January 1979, Acta medica Iugoslavica,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
January 1996, International journal of clinical & laboratory research,
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
January 1973, Series haematologica (1968),
P Gallice, and N Fournier, and A Crevat, and S Saingra, and R Frayssinet, and A Murisasco, and F Sicardi
January 1991, Journal of biochemical toxicology,
Copied contents to your clipboard!